Relation of Contrast-Induced Nephropathy to Long-Term Mortality After Percutaneous Coronary Intervention

Mitsuru Abe(Kyoto Medical Center), Takeshi Kimura(Municipal Hirakata City Hospital), Hirokazu Mitsuoka(Kishiwada City Hospital), Masanao Toma(Hyogo Prefectural Amagasaki General Medical Center), Naritatsu Saito(Foundation for Biomedical Research), Ryoji Taniguchi(Hyogo Prefectural Amagasaki General Medical Center), Masaharu Akao(Kyoto Medical Center), Kozo Hoshino(Naga Municipal Hospital), Takahiro Doi(Fujieda Municipal General Hospital), Satoshi Shizuta(Kyoto University), Natsuhiko Ehara(Kyoto University Hospital), Yutaka Furukawa(Kobe City Medical Center General Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Takeshi Morimoto(Hyogo Medical University), Toshihiro Tamura(Tenri Hospital), Toru Kita(Hyogo Medical University), Neiko Ozasa(Kyoto University), Yoshisumi Haruna(Foundation for Biomedical Research), Kei Nishiyama(Foundation for Biomedical Research)
The American Journal of Cardiology
May 16, 2014
10.1016/j.amjcard.2014.05.009
Cited by 105

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359